David P. Southwell, President and CEO at INOTEK PHARMACEUTICALS CORP (ITEK), bought 60,000 shares at $1.75 ($105K) on 2017-01-06, disclosed to the SEC on 2017-01-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |